Therapeutic area Bioinformatics and Diagnostics
Background info
Indication
Advantages
Intellectual property
Owner/lead

What the technology does

A simple biomarker signature for the diagnosis of TB from sputum samples, suitable for a lateral flow diagnostic test.

Advantage

A specific and sensitive (96% correct classification) test that is stable, rapid, inexpensive and suitable for use at the point of care (i.e. in a non-laboratory setting).

Main application field

TB diagnosis

Usage

Diagnostic

Status

Ready for development with a suitable platform.

Intellectual Property

National phase applications in multiple territories, with a priority date of 18/09/2013 (PCT publication number WO15/040377)

Offering

Collaborative development and exclusive or non-exclusive licence

  • Hidden
  • In submitting your personal data via this form, you consent to being contacted via the details provided so that your enquiry can be responded to. A backup of your data will be held but only authorised individuals will be able to access your data. If you would like your data to be removed, please email dataprivacy@lifearc.org.
    Please see our Privacy policy in relation to the personal data you submit to us through this page.
All Licensing Opportunities